Biology Reference
In-Depth Information
to date demonstrate proof of concept and underline the high potential of
VNPs and VLPs as novel candidate materials for medical devices. The next
hurdle will be to gain a better understanding of the physiological fate and
potential long-term side effects of VNPs. It is anticipated that further
development of VNPs for applications in medicine will be an exciting field
to follow.
references
Acosta-Ramirez, E., Perez-Flores, R., Majeau`, N., Pastelin-Palacios, R., Gil-Cruz,
C., Ramirez-Saldana, M., Manjarrez-Orduno, N., Cervantes-Barragan, L., Santos-
Argumedo, L., Flores-Romo, L., Becker, I., Isibasi, A., Leclerc, D., and Lopez-Macias,
C. (2008) Translating innate response into long-lasting antibody response by the
intrinsic antigen-adjuvant properties of papaya mosaic virus,
Immunology
,
124
(2),
186-197.
Aime, S., Cabella, C., Colombatto, S., Geninatti Crich, S., Gianolio, E., and Maggioni,
F. (2002) Insights into the use of paramagnetic Gd(III) complexes in MR-molecular
imaging investigations,
J. Magn. Reson. Imaging
,
16
(4), 394-406.
Ali, M., Lemoine, N. R., and Ring, C. J. (1994) The use of DNA viruses as vectors for
gene therapy.
Gene Ther.
,
1
(6), 367-384.
Allen, M., Bulte, J. W., Liepold, L., Basu, G., Zywicke, H. A., Frank, J. A., Young, M., and
Douglas, T. (2005) Paramagnetic viral nanoparticles as potential high-relaxivity
magnetic resonance contrast agents,
Magn. Reson. Med.
,
54
(4), 807-812.
Anderson, E. A., Isaacman, S., Peabody, D. S., Wang, E. Y., Canary, J. W., and Kirshenbaum,
K. (2006) Viral nanoparticles donning a paramagnetic coat: conjugation of MRI
contrast agents to the MS2 capsid,
Nano Lett.
,
6
(6), 1160-1164.
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H.
M., Bredesen, d. E., Pasqualini, R., and Ruoslahti, E. (2002) Targeting the prostate for
destruction through a vascular address,
Proc. Natl Acad. Sci. USA
,
99
, 1527-1531.
Bar, H., Yacoby, I., and Benhar, I. (2008) Killing cancer cells by targeted drug-carrying
phage nanomedicines,
BMC Biotechnol.
,
8
, 37.
Barzon, L., Stefani, A. L., Pacenti, M., and Palu, G. (2005) Versatility of gene therapy
vectors through viruses,
Expert Opin. Biol. Ther.
,
5
(5), 639-662.
Bawarski, W. E., Chidlowsky, E., Bharali, D. J., and Mousa, S. A. (2008) Emerging
nanopharmaceuticals,
Nanomedicine
,
4
(4), 273-282.
Becker, A., Riefke, B., Ebert, B., Sukowski, U., Rinneberg, H., Semmler, W., and Licha, K.
(2000) Macromolecular contrast agents for optical imaging of tumors: comparison
of indotricarbocyanine-labeled human serum albumin and transferrin,
Photochem.
Photobiol.
,
72
(2), 234-241.
Search WWH ::
Custom Search